psoriasis

Dermavant CEO draws Botox comparison to instill Vtama confidence amid slow psoriasis uptake
Dermavant CEO draws Botox comparison to instill Vtama confidence amid slow psoriasis uptake
Fierce Pharma
Dermavant
Vtama
psoriasis
Botox
Flag link:
Even with phase 2 success, Ventyx halts TYK2 inhibitor, sending stock plummeting 70%
Even with phase 2 success, Ventyx halts TYK2 inhibitor, sending stock plummeting 70%
Fierce Biotech
Ventyx Biosciences
clinical trials
TYK2 inhibitors
VTX958
psoriasis
Flag link:
Janssen tackles racial gap in Phase IIIb psoriasis trial with Tremfya
Janssen tackles racial gap in Phase IIIb psoriasis trial with Tremfya
Clinical Trials Arena
Janssen
psoriasis
Tremfya
clinical trials
Flag link:
UCB Wins FDA Approval for Plaque Psoriasis Therapy After Regulatory Setbacks
UCB Wins FDA Approval for Plaque Psoriasis Therapy After Regulatory Setbacks
BioSpace
UCB
bimekizumab
psoriasis
FDA
Bimzelx
Flag link:
Beaten by placebo, Evelo seeks partner for once-lauded microbiome platform and programs
Beaten by placebo, Evelo seeks partner for once-lauded microbiome platform and programs
Fierce Biotech
Evelo Biosciences
microbiome
clinical trials
psoriasis
Flag link:
AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis
AbbVie's Skyrizi delivers head-to-head win versus Amgen's Otezla in psoriasis
Fierce Pharma
AbbVie
Skyrizi
Amgen
Otezla
Boehringer Ingelheim
psoriasis
Flag link:
BMS’ Sotyktu cleared for NHS use in psoriasis
BMS’ Sotyktu cleared for NHS use in psoriasis
Pharmaphorum
Bristol Myers Squibb
Sotyktu
psoriasis
NHS
UK
Flag link:
Johnson & Johnson’s Tremfya outshines IL-17 inhibitors as plaque psoriasis treatment
Johnson & Johnson’s Tremfya outshines IL-17 inhibitors as plaque psoriasis treatment
Clinical Trials Arena
JNJ
Janssen
Tremfya
psoriasis
real world data
Flag link:
Immunic punts psoriasis, prostate cancer programs to narrow focus onto multiple sclerosis, celiac disease
Immunic punts psoriasis, prostate cancer programs to narrow focus onto multiple sclerosis, celiac disease
Fierce Biotech
Immunic
prostate cancer
psoriasis
MS
multiple sclerosis
celiac disease
Flag link:
Acquired patents aid J&J defense of top-selling drug from biosimilar challenge
Acquired patents aid J&J defense of top-selling drug from biosimilar challenge
BioPharma Dive
Amgen
JNJ
Stelara
psoriasis
patents
biosimilars
Flag link:
Biohaven strikes a deal to take TYK2 drugs in a new direction
Biohaven strikes a deal to take TYK2 drugs in a new direction
BioPharma Dive
Biohaven
Pfizer
Hangzhou Highlightll
psoriasis
Flag link:
AbbVie’s Skyrizi hits the spot in refractory psoriasis
AbbVie’s Skyrizi hits the spot in refractory psoriasis
Pharmaphorum
AbbVie
Skyrizi
psoriasis
Flag link:
Takeda focuses on ‘diverse’ pipeline prospects on heels of two acquisitions
Takeda focuses on ‘diverse’ pipeline prospects on heels of two acquisitions
Endpoints
Takeda
Nimbus Therapeutics
Hutchmed
colorectal cancer
psoriasis
fruquintinib
Flag link:
UCB's bimekizumab finally back on the FDA's review list after May rejection
UCB's bimekizumab finally back on the FDA's review list after May rejection
Fierce Pharma
UCB Pharma
psoriasis
bimekizumab
FDA
Flag link:
Dr. Reddy's subsidiary hits the pause button on drug development for psoriasis
Dr. Reddy's subsidiary hits the pause button on drug development for psoriasis
Endpoints
Dr Reddy's
psoriasis
Aurigene
clinical trials
AUR101
Flag link:
Nimbus hopes to best Bristol’s Sotyktu
Nimbus hopes to best Bristol’s Sotyktu
EP Vantage
Bristol Myers Squibb
Sotyktu
Nimbus
NDI-034858
psoriasis
Flag link:
The other shoe drops for Immunic
The other shoe drops for Immunic
EP Vantage
Immunic
IMU-935
psoriasis
Flag link:
A biologic’s efficacy in a pill: Dice posts first human data for oral psoriasis med
A biologic’s efficacy in a pill: Dice posts first human data for oral psoriasis med
MedCity News
DiCE Therapeutics
biologics
psoriasis
DC-806
Flag link:
Nimbus raises $125M to advance rival to Bristol Myers’ new psoriasis drug
Nimbus raises $125M to advance rival to Bristol Myers’ new psoriasis drug
BioPharma Dive
Nimbus Therapeutics
psoriasis
Bristol Myers Squibb
Sotyktu
Flag link:
Bristol Myers gets FDA approval for new type of psoriasis drug
Bristol Myers gets FDA approval for new type of psoriasis drug
BioPharma Dive
Bristol Myers Squibb
Sotyktu
FDA
psoriasis
Flag link:

Pages